nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—osteoarthritis—Prednisone—multiple sclerosis	0.27	0.5	CpDpCtD
Piroxicam—osteoarthritis—Methylprednisolone—multiple sclerosis	0.27	0.5	CpDpCtD
Piroxicam—ALB—multiple sclerosis	0.188	1	CbGaD
Piroxicam—PTGS2—Triamcinolone—multiple sclerosis	0.0521	0.201	CbGbCtD
Piroxicam—PTGS2—Betamethasone—multiple sclerosis	0.0447	0.172	CbGbCtD
Piroxicam—SLC22A11—Methotrexate—multiple sclerosis	0.0382	0.147	CbGbCtD
Piroxicam—ALB—Prednisone—multiple sclerosis	0.0263	0.101	CbGbCtD
Piroxicam—PTGS2—Dexamethasone—multiple sclerosis	0.026	0.1	CbGbCtD
Piroxicam—SLC22A8—Methotrexate—multiple sclerosis	0.0222	0.0855	CbGbCtD
Piroxicam—SLC22A6—Methotrexate—multiple sclerosis	0.0155	0.0596	CbGbCtD
Piroxicam—ALB—Methotrexate—multiple sclerosis	0.0132	0.0508	CbGbCtD
Piroxicam—CYP2C8—Dexamethasone—multiple sclerosis	0.0127	0.0488	CbGbCtD
Piroxicam—CYP2C9—Dexamethasone—multiple sclerosis	0.00884	0.034	CbGbCtD
Piroxicam—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000428	0.159	CbGdCrCtD
Piroxicam—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000421	0.156	CbGdCrCtD
Piroxicam—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000421	0.156	CbGdCrCtD
Piroxicam—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000411	0.153	CbGdCrCtD
Piroxicam—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000258	0.0957	CbGdCrCtD
Piroxicam—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000254	0.0942	CbGdCrCtD
Piroxicam—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000254	0.0942	CbGdCrCtD
Piroxicam—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000248	0.0921	CbGdCrCtD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.64e-05	0.00944	CbGpPWpGaD
Piroxicam—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	8.45e-05	0.00924	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	7.97e-05	0.00872	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	7.76e-05	0.00848	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	7.6e-05	0.00831	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	7.6e-05	0.00831	CbGpPWpGaD
Piroxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	7.52e-05	0.00822	CbGpPWpGaD
Piroxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	7.52e-05	0.00822	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—PLEK—multiple sclerosis	7.34e-05	0.00802	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	7.25e-05	0.00793	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	7.11e-05	0.00777	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	6.99e-05	0.00764	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	6.93e-05	0.00758	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	6.63e-05	0.00725	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	6.59e-05	0.0072	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.04e-05	0.0066	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.79e-05	0.00633	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.5e-05	0.00601	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	5.36e-05	0.00586	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	5.25e-05	0.00574	CbGpPWpGaD
Piroxicam—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	5.17e-05	0.00565	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	5.16e-05	0.00564	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	5.02e-05	0.00549	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	4.91e-05	0.00537	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	4.91e-05	0.00537	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.84e-05	0.00529	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.84e-05	0.00529	CbGpPWpGaD
Piroxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.78e-05	0.00523	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	4.69e-05	0.00513	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.6e-05	0.00503	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	4.6e-05	0.00503	CbGpPWpGaD
Piroxicam—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	4.47e-05	0.00489	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.42e-05	0.00483	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.39e-05	0.0048	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	4.33e-05	0.00473	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	4.26e-05	0.00465	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	4.2e-05	0.0046	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	4.17e-05	0.00456	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	4.12e-05	0.00451	CbGpPWpGaD
Piroxicam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	4.02e-05	0.0044	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	3.99e-05	0.00437	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	3.99e-05	0.00437	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.94e-05	0.00431	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.94e-05	0.00431	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.84e-05	0.0042	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	3.77e-05	0.00412	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.69e-05	0.00403	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	3.64e-05	0.00398	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.47e-05	0.00379	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	3.43e-05	0.00376	CbGpPWpGaD
Piroxicam—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	3.43e-05	0.00375	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	3.38e-05	0.00369	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.35e-05	0.00366	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	3.25e-05	0.00356	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL4—multiple sclerosis	3.25e-05	0.00355	CbGpPWpGaD
Piroxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.22e-05	0.00352	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	3.19e-05	0.00349	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	3.17e-05	0.00347	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.07e-05	0.00335	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	3.03e-05	0.00332	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	3.03e-05	0.00331	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.92e-05	0.00319	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.92e-05	0.00319	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.86e-05	0.00313	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	2.86e-05	0.00312	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	2.84e-05	0.00311	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.79e-05	0.00305	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	2.72e-05	0.00297	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—CD58—multiple sclerosis	2.72e-05	0.00297	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SELPLG—multiple sclerosis	2.72e-05	0.00297	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—MERTK—multiple sclerosis	2.72e-05	0.00297	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	2.69e-05	0.00295	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	2.66e-05	0.00291	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.65e-05	0.00289	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—ICAM1—multiple sclerosis	2.58e-05	0.00282	CbGpPWpGaD
Piroxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.56e-05	0.0028	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.54e-05	0.00277	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	2.52e-05	0.00276	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.43e-05	0.00266	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	2.41e-05	0.00264	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.34e-05	0.00256	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.32e-05	0.00253	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.32e-05	0.00253	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—CCL2—multiple sclerosis	2.31e-05	0.00253	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.3e-05	0.00252	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.27e-05	0.00248	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.25e-05	0.00246	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.21e-05	0.00241	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.2e-05	0.00241	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.17e-05	0.00238	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.17e-05	0.00237	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	2.15e-05	0.00236	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	2.11e-05	0.00231	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.1e-05	0.00229	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	2.09e-05	0.00229	CbGpPWpGaD
Piroxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.09e-05	0.00228	CbGpPWpGaD
Piroxicam—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.08e-05	0.00227	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.05e-05	0.00224	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	2e-05	0.00219	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2e-05	0.00218	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IFNG—multiple sclerosis	1.96e-05	0.00215	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	1.96e-05	0.00215	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.95e-05	0.00213	CbGpPWpGaD
Piroxicam—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	1.93e-05	0.00211	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.93e-05	0.00211	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.92e-05	0.0021	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.88e-05	0.00206	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.88e-05	0.00206	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.87e-05	0.00205	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.87e-05	0.00205	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.85e-05	0.00202	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—SRM—multiple sclerosis	1.84e-05	0.00202	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.84e-05	0.00201	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	1.79e-05	0.00196	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL1B—multiple sclerosis	1.75e-05	0.00192	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL2—multiple sclerosis	1.75e-05	0.00191	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.72e-05	0.00188	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—POMC—multiple sclerosis	1.71e-05	0.00187	CbGpPWpGaD
Piroxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.69e-05	0.00185	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PLEK—multiple sclerosis	1.68e-05	0.00183	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.66e-05	0.00181	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.58e-05	0.00173	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	1.57e-05	0.00172	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	1.56e-05	0.00171	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.56e-05	0.00171	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.53e-05	0.00168	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.53e-05	0.00168	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	1.53e-05	0.00167	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—SRM—multiple sclerosis	1.46e-05	0.0016	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.45e-05	0.00159	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.39e-05	0.00152	CbGpPWpGaD
Piroxicam—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	1.39e-05	0.00152	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.38e-05	0.00151	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	1.36e-05	0.00149	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	1.36e-05	0.00148	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CYP24A1—multiple sclerosis	1.3e-05	0.00142	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CYP27B1—multiple sclerosis	1.3e-05	0.00142	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	1.28e-05	0.0014	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—TNF—multiple sclerosis	1.27e-05	0.00139	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.27e-05	0.00139	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	1.27e-05	0.00139	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.26e-05	0.00138	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	1.25e-05	0.00137	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—SRM—multiple sclerosis	1.19e-05	0.0013	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GPC5—multiple sclerosis	1.19e-05	0.0013	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SRM—multiple sclerosis	1.18e-05	0.00129	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SELE—multiple sclerosis	1.18e-05	0.00129	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—TGFB1—multiple sclerosis	1.17e-05	0.00128	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.15e-05	0.00126	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.13e-05	0.00124	CbGpPWpGaD
Piroxicam—PTGS2—Disease—GPC5—multiple sclerosis	1.13e-05	0.00123	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.11e-05	0.00122	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.1e-05	0.00121	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—POMC—multiple sclerosis	1.1e-05	0.00121	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	1.06e-05	0.00116	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	1.06e-05	0.00116	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	1.04e-05	0.00113	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CYP27B1—multiple sclerosis	1.03e-05	0.00113	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CYP24A1—multiple sclerosis	1.03e-05	0.00113	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—IL6—multiple sclerosis	1.03e-05	0.00112	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.01e-05	0.00111	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1.01e-05	0.0011	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.01e-05	0.0011	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	1.01e-05	0.0011	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	9.87e-06	0.00108	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—RRM1—multiple sclerosis	9.84e-06	0.00108	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SRM—multiple sclerosis	9.69e-06	0.00106	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GPC5—multiple sclerosis	9.43e-06	0.00103	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—POMC—multiple sclerosis	8.98e-06	0.000982	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—ITGA4—multiple sclerosis	8.54e-06	0.000934	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IFNB1—multiple sclerosis	8.48e-06	0.000928	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.42e-06	0.000921	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	8.39e-06	0.000918	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	8.39e-06	0.000918	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CYP24A1—multiple sclerosis	8.34e-06	0.000912	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CYP27B1—multiple sclerosis	8.34e-06	0.000912	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.2e-06	0.000897	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.15e-06	0.000892	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	8.15e-06	0.000891	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	7.97e-06	0.000871	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—RRM1—multiple sclerosis	7.82e-06	0.000855	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GPC5—multiple sclerosis	7.67e-06	0.000839	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.64e-06	0.000835	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GPC5—multiple sclerosis	7.63e-06	0.000834	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RPL5—multiple sclerosis	7.32e-06	0.000801	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.21e-06	0.000789	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.19e-06	0.000787	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.05e-06	0.000771	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.03e-06	0.000769	CbGpPWpGaD
Piroxicam—PTGS2—Disease—SLC11A1—multiple sclerosis	7.01e-06	0.000767	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	6.83e-06	0.000747	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	6.83e-06	0.000747	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.72e-06	0.000735	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.67e-06	0.00073	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.64e-06	0.000726	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.56e-06	0.000718	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—RRM1—multiple sclerosis	6.36e-06	0.000695	CbGpPWpGaD
Piroxicam—ALB—Metabolism—RRM1—multiple sclerosis	6.32e-06	0.000691	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GPC5—multiple sclerosis	6.25e-06	0.000683	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.06e-06	0.000663	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.98e-06	0.000654	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IL2RA—multiple sclerosis	5.84e-06	0.000638	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—BCHE—multiple sclerosis	5.65e-06	0.000618	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD28—multiple sclerosis	5.6e-06	0.000612	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.21e-06	0.00057	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.18e-06	0.000566	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.18e-06	0.000566	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	5.08e-06	0.000555	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.93e-06	0.00054	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.91e-06	0.000536	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.75e-06	0.000519	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—BCHE—multiple sclerosis	4.49e-06	0.000491	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.24e-06	0.000463	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.21e-06	0.000461	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.02e-06	0.000439	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD86—multiple sclerosis	4e-06	0.000437	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.86e-06	0.000423	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—BCHE—multiple sclerosis	3.65e-06	0.000399	CbGpPWpGaD
Piroxicam—ALB—Metabolism—BCHE—multiple sclerosis	3.63e-06	0.000397	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CCR5—multiple sclerosis	3.54e-06	0.000388	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HLA-A—multiple sclerosis	3.45e-06	0.000378	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.45e-06	0.000377	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IL2—multiple sclerosis	3.42e-06	0.000374	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—APOE—multiple sclerosis	3.4e-06	0.000372	CbGpPWpGaD
Piroxicam—PTGS2—Disease—APOE—multiple sclerosis	3.22e-06	0.000353	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.14e-06	0.000344	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.97e-06	0.000325	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—POMC—multiple sclerosis	2.92e-06	0.00032	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD80—multiple sclerosis	2.92e-06	0.000319	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—APOE—multiple sclerosis	2.7e-06	0.000295	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TGFB1—multiple sclerosis	2.67e-06	0.000292	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ALB—multiple sclerosis	2.66e-06	0.000291	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—MAPK1—multiple sclerosis	2.62e-06	0.000286	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TYK2—multiple sclerosis	2.46e-06	0.000269	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—POMC—multiple sclerosis	2.32e-06	0.000254	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD4—multiple sclerosis	2.23e-06	0.000243	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—APOE—multiple sclerosis	2.2e-06	0.00024	CbGpPWpGaD
Piroxicam—ALB—Metabolism—APOE—multiple sclerosis	2.18e-06	0.000239	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ALB—multiple sclerosis	2.11e-06	0.000231	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—POMC—multiple sclerosis	1.89e-06	0.000206	CbGpPWpGaD
Piroxicam—ALB—Metabolism—POMC—multiple sclerosis	1.88e-06	0.000205	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—APOE—multiple sclerosis	1.79e-06	0.000196	CbGpPWpGaD
Piroxicam—PTGS2—Disease—STAT3—multiple sclerosis	1.72e-06	0.000188	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ALB—multiple sclerosis	1.72e-06	0.000188	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MYC—multiple sclerosis	1.6e-06	0.000175	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TGFB1—multiple sclerosis	1.6e-06	0.000175	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MAPK1—multiple sclerosis	1.57e-06	0.000171	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—POMC—multiple sclerosis	1.54e-06	0.000168	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ALB—multiple sclerosis	1.4e-06	0.000153	CbGpPWpGaD
Piroxicam—PTGS2—Disease—IL6—multiple sclerosis	1.2e-06	0.000132	CbGpPWpGaD
